PHP
AXGN icon

Parkman Healthcare Partners’s Axogen AXGN Stock Holding History

Parkman Healthcare Partners’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.88M Buy
268,160
+17,842
+7% +$580K 0.92% 41
2025
Q4 		$8.19M Sell
250,318
-251,514
-50% -$6.19M 0.78% 44
2025
Q3 		$8.95M Sell
501,832
-172,719
-26% -$2.51M 0.93% 38
2025
Q2 		$7.32M Buy
674,551
+137,719
+26% +$1.8M 0.84% 45
2025
Q1 		$9.93M Buy
536,832
+171,129
+47% +$3.09M 1.18% 30
2024
Q4 		$6.03M Sell
365,703
-47,185
-11% -$668K 0.8% 42
2024
Q3 		$5.79M Buy
+412,888
New +$4.57M 0.74% 47
2023
Q3 		– Sell
-260,858
Closed -$2.38M – 103
2023
Q2 		$2.38M Buy
260,858
+37,075
+17% +$346K 0.41% 69
2023
Q1 		$2.11M Buy
223,783
+33,728
+18% +$308K 0.46% 56
2022
Q4 		$1.9M Sell
190,055
-9,945
-5% -$110K 0.51% 58
2022
Q3 		$2.38M Buy
200,000
+11,506
+6% +$115K 0.68% 52
2022
Q2 		$1.54M Buy
188,494
+59,547
+46% +$509K 0.57% 48
2022
Q1 		$1.02M Sell
128,947
-77,651
-38% -$671K 0.3% 67
2021
Q4 		$1.94M Buy
206,598
+6,598
+3% +$79.1K 0.43% 60
2021
Q3 		$3.16M Sell
200,000
-37,652
-16% -$676K 0.8% 37
2021
Q2 		$5.14M Buy
237,652
+26,053
+12% +$527K 1.12% 34
2021
Q1 		$4.29M Sell
211,599
-18,910
-8% -$373K 1% 34
2020
Q4 		$4.13M Buy
230,509
+105,509
+84% +$1.55M 1.06% 39
2020
Q3 		$1.45M Buy
+125,000
New +$1.45M 0.39% 66

Other funds holding AXGN

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkman Healthcare Partners's AXGN Position: Q1 2026 in Review

Parkman Healthcare Partners increased its Axogen (AXGN) stake by 7.1% in Q1 2026, buying an estimated $580K and bringing the position to 268,160 shares worth $8.88M. The position accounts for 0.92% of the portfolio, ranked #41.

Parkman Healthcare Partners first reported a position in AXGN in Q3 2020 and has held it in 19 quarters since. The position peaked at $9.93M in Q1 2025. 220 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Parkman Healthcare Partners held 268,160 shares of Axogen worth $8.88M as of Q1 2026.
  • Parkman Healthcare Partners bought 17,842 Axogen shares in Q1 2026, an estimated $580K.
  • Axogen made up 0.92% of Parkman Healthcare Partners's portfolio in Q1 2026, its #41 holding.
  • Parkman Healthcare Partners first reported a position in Axogen in Q3 2020 and has held it in 19 quarters since.
  • Parkman Healthcare Partners's Axogen position peaked at $9.93M in Q1 2025.
  • 220 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.